share_log
Moomoo 24/7 ·  Apr 11 09:09
Candel Therapeutics Shares Are Trading Higher After the Company Received FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment